Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The trajectory of change for children and youth in residential treatment.

Noftle JW, Cook S, Leschied A, St Pierre J, Stewart SL, Johnson AM.

Child Psychiatry Hum Dev. 2011 Feb;42(1):65-77. doi: 10.1007/s10578-010-0200-7.

PMID:
20737286
2.

Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study.

Levine SZ, Rabinowitz J, Case M, Ascher-Svanum H.

J Clin Psychopharmacol. 2010 Aug;30(4):446-9. doi: 10.1097/JCP.0b013e3181e68e80.

PMID:
20631562
3.

Lack of concordance between subjective improvement and symptom change in psychotic episodes.

Kupper Z, Tschacher W.

Br J Clin Psychol. 2008 Mar;47(Pt 1):75-93.

PMID:
17927846
4.

Concordance of patient and clinical ratings of symptom severity and change of psychotic illness.

Rabinowitz J, Levine SZ, Medori R, Oosthuizen P, Koen L, Emsley R.

Schizophr Res. 2008 Mar;100(1-3):359-60. Epub 2008 Feb 20. No abstract available.

PMID:
18077138
5.

Evaluation of a multi-element treatment center for early psychosis in the United States.

Uzenoff SR, Penn DL, Graham KA, Saade S, Smith BB, Perkins DO.

Soc Psychiatry Psychiatr Epidemiol. 2012 Oct;47(10):1607-15. doi: 10.1007/s00127-011-0467-4. Epub 2012 Jan 26.

PMID:
22278376
6.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
7.

Evaluation and treatment of children and adolescents with psychotic symptoms.

Algon S, Yi J, Calkins ME, Kohler C, Borgmann-Winter KE.

Curr Psychiatry Rep. 2012 Apr;14(2):101-10. doi: 10.1007/s11920-012-0258-y. Review.

8.

Psychoses in children and adolescents: a review.

Tolbert HA.

J Clin Psychiatry. 1996;57 Suppl 3:4-8; discussion 46-7. Review.

PMID:
8626370
9.

Trajectories and antecedents of treatment response over time in early-episode psychosis.

Levine SZ, Rabinowitz J.

Schizophr Bull. 2010 May;36(3):624-32. doi: 10.1093/schbul/sbn120. Epub 2008 Oct 9.

10.

To what extent do the PANSS and CGI-S overlap?

Rabinowitz J, Mehnert A, Eerdekens M.

J Clin Psychopharmacol. 2006 Jun;26(3):303-7.

PMID:
16702895
11.

Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.

Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):327-36. doi: 10.1089/cap.2007.0138.

PMID:
18759642
12.

Antisocial behavioral syndromes among residential drug abuse treatment clients.

Goldstein RB, Powers SI, McCusker J, Lewis BF, Bigelow C, Mundt KA.

Drug Alcohol Depend. 1999 Jan 7;53(2):171-87.

PMID:
10080043
13.

Neurocognitive growth charting in psychosis spectrum youths.

Gur RC, Calkins ME, Satterthwaite TD, Ruparel K, Bilker WB, Moore TM, Savitt AP, Hakonarson H, Gur RE.

JAMA Psychiatry. 2014 Apr;71(4):366-74. doi: 10.1001/jamapsychiatry.2013.4190.

PMID:
24499990
14.
15.

Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.

Vernal DL, Kapoor S, Al-Jadiri A, Sheridan EM, Borenstein Y, Mormando C, David L, Singh S, Seidman AJ, Carbon M, Gerstenberg M, Saito E, Kane JM, Steinhausen HC, Correll CU.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):535-47. doi: 10.1089/cap.2014.0164.

16.

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.

Davidson M, Harvey PD, Vervarcke J, Gagiano CA, De Hooge JD, Bray G, Dose M, Barak Y, Haushofer M.

Int J Geriatr Psychiatry. 2000 Jun;15(6):506-14.

PMID:
10861916
17.

Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.

Bingham KS, Whyte EM, Meyers BS, Mulsant BH, Rothschild AJ, Banerjee S, Flint AJ; STOP-PD Study Group.

Am J Geriatr Psychiatry. 2015 Dec;23(12):1270-1275. doi: 10.1016/j.jagp.2015.08.002. Epub 2015 Aug 20.

18.

Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.

Drake RE, McHugo GJ, Xie H, Fox M, Packard J, Helmstetter B.

Schizophr Bull. 2006 Jul;32(3):464-73. Epub 2006 Mar 8.

19.

Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.

Hides L, Dawe S, Kavanagh DJ, Young RM.

Br J Psychiatry. 2006 Aug;189:137-43.

20.

Interpersonal pathoplasticity and trajectories of change in routine adolescent and young adult residential substance abuse treatment.

Boswell JF, Cain NM, Oswald JM, McAleavey AA, Adelman R.

J Consult Clin Psychol. 2017 Jul;85(7):676-688. doi: 10.1037/ccp0000219. Epub 2017 May 15.

PMID:
28504541

Supplemental Content

Support Center